Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

The Hormone Replacement Therapy Market is estimated to grow at a CAGR of 6.48% during the forecast period from 2024 to 2030.

Rheumatologists and dermatologists highlight Saphnelo, Sotyktu, and litifilimab as leading candidates to address unmet needs in CLE patients, particu ...

Henkel delivered solid results in 2024 and is in excellent financial shape. Click here to read an analysis of HENKY stock now ...

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

A tricky buy-out clause coupled with the start date of the FIFA Club World Cup is complicating BVB’s intentions with Carney ...

Borussia Dortmund have agreed a new deal with Under-19 head coach Mike Tullberg, the club have announced. In the process of ...

ESG/SustainabilityAsklepios Group: Publication of Asklepios CSRD Report 2024 30.04.2025 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Asklepios Group: ...

DWS Group GmbH & Co KGaA reports robust financial performance with significant net inflows and strategic initiatives, despite challenges in active equity strategies and market volatility.

Quarter Results/ForecastDrägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025 30.04.2025 / 07:30 CET/CESTThe issuer is solely responsible for the content of this ...

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

Germany’s Merck KGaA has agreed to acquire U.S. biotech SpringWorks Therapeutics for $3.9 billion. The acquisition, aimed at ...